The results of a long-term follow up of patients with age-related macular degeneration who received a lutein-containing medication

Abstract

The paper presents the results of a seven-year follow-up of 158 patients who originally had early or intermediate AMD in both eyes and regularly received courses of Vitrum Vision Forte, in comparison to the data of 147 patients with a similar initial clinical status who, for various reasons, however failed to receive regular treatment. In the case of early AMD patients receiving regular courses of treatment, the progression rate to the late stage amounted to 0.7 % and to the intermediate stage, to 28.5 %. If no systematic treatment was administered, the progression rate was, respectively, 4 and 38 %. In the case of intermediate AMD patients, the progression rate to the late stage amounted to 18.6 % in patients receiving Vitrum Vision Forte and reached the mark of 30 % in the absence of regular treatment. So, regular courses of Vitrum Vision Forte reduce the progression rate of AMD, promote long-term maintenance of high visual acuity and quality of visual functions in patients with retinal drusen // Russian Ophthalmological Journal, 2016; 2: 70-6 . doi: 10.21516/2072-0076-2016-9-2-70-76 .

Keywords

• возрастная макулярная дегенерация
• прогрессирование
• витрум® вижн форте
• лечение
• age-related macular degeneration
• progression
• vitrum vision forte
• treatment